Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients
Condition(s):Breast CancerLast Updated:May 13, 2016Suspended
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:May 13, 2016Suspended
Condition(s):Healthy VolunteersLast Updated:February 8, 2023Completed
Condition(s):NeoplasmsLast Updated:March 31, 2017Completed
Condition(s):Breast NeoplasmsLast Updated:January 7, 2015Completed
Condition(s):HER-2 Positive Gastric Cancer; Liver MetastasisLast Updated:March 5, 2015Unknown status
Condition(s):Breast CancerLast Updated:April 29, 2016Completed
Condition(s):Breast NeoplasmsLast Updated:April 27, 2021Completed
Condition(s):Human Epithelial Receptor (HER)-2 Positive Breast CancerLast Updated:November 29, 2018Completed
Condition(s):Breast CancerLast Updated:October 13, 2016Unknown status
Condition(s):BREAST CANCERLast Updated:February 7, 2017Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.